View Published SNOMED CT Subset Metadata

Indicators no longer in Quality and Outcomes Framework general practice extraction - direct renin inhibitors


Subset Name :   
Indicators no longer in Quality and Outcomes Framework general practice extraction - direct renin inhibitors
Subset Type :   
Realm Concept

Refset FSN :   
Indicators no longer in Quality and Outcomes Framework general practice extraction - direct renin inhibitors simple reference set (foundation metadata concept)
Refset Id :   
999000971000001108
Refset Type :   
Simple

Subset Description :
This subset identifies the direct renin inhibitors drugs as specified in the Chronic kidney disease (CKD) Indicators no longer in QOF business rules. This subset may contain invalid concepts. All VMPs and AMPs associated with the following VTM: Aliskiren

Status

Subset Status :   
Draft for Trial Use
Subset Status Date :   
Jul 11, 2018
Owner (Organisation name) :   
NHS Digital

Purpose and Scope

Usage 1 :

   
Usage Type :    
Intended
Usage Description :    
Intended for secondary uses purposes. Information to support the calculation of Indicators no longer in the Quality Outcomes Framework. This reference set is used in the Indicator NM84: The percentage of patients on the CKD register with hypertension and proteinuria who are currently treated with renin-angiotensin system antagonists. NICE Guideline: Chronic kidney disease in adults: assessment and management (CG182) Clinical guideline Published July 2014 Last updated January 2015
Geographic Usage :    
England
Usage Category:    
 Quality Outcome Framework


Scope :

   
Inclusion Criteria :   
Age group - any age; Gender - not specified; Sex - not specified
Subject Category :   
Prescribing; Chemicals and Drugs

Publication

Subset Release Category :   
UK Drug Extension
Language :   
en

Subset Licence Type :   
IHTSDO SNOMED CT® Licence; UKTC SNOMED CT® Licence; Open Government Licence

Metadata Version :   
1.0
Last Updated :   
Nov 20, 2018

Related Links

Subset download with descriptions :

UK Drug Extension releases